Wednesday, 28 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Promoter Reclassification

Bliss GVS Pharma Promoter Reclassification

Bliss GVS Pharma announced a change in control, with Anupam Rasayan India and Mates Visa Consultancy becoming the new promoters. The board also reconstituted the leadership team.

Source

BSE filing, NSE: BLISSGVS. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Bliss GVS Pharma Ltd: key numbers

Share price
₹648.50
Market cap
₹6,899 Cr
Revenue (annual)
₹927.1 Cr
Net profit (annual)
₹129.1 Cr
P/E (TTM)
50.7×Sector 46.1×
Promoter holding
50.07%+15.06% QoQ
FII holding
5.03%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Bliss GVS Pharma Ltd

All →

Other promoter reclassification announcements

All →